ArticleScientific reports2026

Synergistic targeting of the ARID2-MYC axis by pomalidomide and panobinostat overcomes intrinsic IMiD resistance in multiple myeloma.

Junichi Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.